4.0 Article

Analysis and comparison of autologous platelet-rich plasma preparation systems used in the treatment of enthesopathies: A preliminary study

Journal

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
Volume 30, Issue 7, Pages 757-764

Publisher

WROCLAW MEDICAL UNIV
DOI: 10.17219/acem/135045

Keywords

platelet-rich plasma; growth factors; platelet-derived growth factor; enthesopathy

Funding

  1. Ministry of Health subvention from the IT Simple system of Wroclaw Medical University [STM.E067.20.112]

Ask authors/readers for more resources

This study compared PRP preparation systems and found that the Mini GPS III system produced PRP with the highest platelet and white blood cell concentrations. Significant differences in EGF and PDGF-AA levels were observed between the Mini GPS III and Arthrex ACP systems. The study showed a positive correlation between platelet content and PDGF-AA and EGF levels, as well as a positive correlation between red blood cell concentration and PDGF-AA, EGF, and VEGF levels.
Background. Autologous platelet-rich plasma (PRP) injection is an alternative but widely accepted method for the treatment of degenerative changes in tendon attachments known as enthesopathies. The PRP is considered a safe source for high concentrations of the growth factors involved in the healing process. Despite initial promising outcomes, many recent studies report conflicting results for this treatment. This may be due to differences in the concentrations of platelets and growth factors in PRPs obtained using different methods. Objectives. The aim of this study was to compare PRP preparation systems in terms of morphotic components and selected growth factors to find the most appropriate procedure for the treatment of enthesopathies. Materials and methods. Whole blood samples from 6 healthy male volunteers were collected. Using different commercial kits (Mini GPS III System, Arthrex ACP, and Xerthra, Dr. PRP), 4 PRPs were prepared from the blood of each participant. All samples were analyzed for the content of morphotic components and the following growth factors: transforming growth factor-beta 1 (TGF-beta 1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and platelet-derived growth factor AA (PDGF-AA). Results. The Mini GPS III produced PRP with the highest concentration of platelets and white blood cells (WBC) compared to the other systems included in the study. Significant differences in the levels of EGF and PDGF-AA were found only between the Mini GPS III and Arthrex ACP. There was positive correlation between the content of platelets and the levels of PDGF-AA and EGF. The red blood cells (RBC) concentration positively correlated with PDGF-AA, EGF and VEGF. Conclusions. This study showed differences between the morphotic components and levels of selected growth factors in PRP obtained with the different preparation methods. Due to insufficient data, we cannot argue for or against any of the studied protocols forthe treatment of enthesopathy. Further studies on a larger population are required to validate our results.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available